This article is more than 5 years old. Information may no longer be current.
Genetic test for color vision deficiency to be available by year's end
Click Here to Manage Email Alerts
ALBUQUERQUE, N.M. — A noninvasive means for consistently distinguishing on a genetic basis individuals with color vision deficiency from those with normal color vision will be available by the end of 2011, according to manufacturer Genevolve Vision Diagnostics.
The test, which will allow for accurate testing of children as young as 6 months, will also allow for classification of color vision deficiencies, according to a company press release.
"The new test is a game changer ... in color vision testing, which had not changed in the last 60+ years," Genevolve president Matt Lemelin said.
Marketed under the name Eyedox, the test will call for epithelial cells to be collected from the lining of the mouth. The cells will then be sent to a certified laboratory where DNA analysis will provide precise identification of inherited color vision deficiencies, along with information on the severity of the deficiency.
Genevolve is also planning further study on gene therapy procedures that have proven effective in treating color vision deficiencies in monkeys.